Minimal change nephrotic syndrome due to certolizumab pegol, an anti-tumor necrosis factor-alpha monoclonal antibody for treatment of rheumatoid arthritis

被引：0
|
作者：
Sugiyama, Masafumi [1 ,2 ]
Okuda, Saki [1 ]
Hirooka, Yasuaki [1 ]
机构：
[1] Kindai Univ, Dept Rheumatol, Nara Hosp, 1248-1 Otodacho, Ikoma, Nara 6300293, Japan
[2] Hashima Municipal Hosp, Dept Rheumatol, Gifu, Japan
来源：
RHEUMATOLOGY ADVANCES IN PRACTICE | 2022年 / 6卷 / 01期
关键词：
D O I：
10.1093/rap/rkac012
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis
    Feldmann, M
    Elliott, MJ
    Woody, JN
    Maini, RN
    [J]. ADVANCES IN IMMUNOLOGY, VOL 64, 1997, 64 : 283 - 350
  • [2] Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis
    Paleolog, EM
    Hunt, M
    Elliott, MJ
    Feldmann, M
    Maini, RN
    Woody, JN
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (07): : 1082 - 1091
  • [3] Certolizumab Pegol: A Polyethylene Glycolated Fab' Fragment of Humanized Anti-Tumor Necrosis Factor Alpha Monoclonal Antibody for the Treatment of Crohn's Disease
    Baker, Danial E.
    [J]. REVIEWS IN GASTROENTEROLOGICAL DISORDERS, 2008, 8 (04) : 240 - 253
  • [4] Adalimumab - A fully human monoclonal anti-tumor necrosis factor-alpha antibody
    Edwards, LA
    [J]. FORMULARY, 2003, 38 (05) : 272 - +
  • [5] Pregnancy and exposure to infliximab (anti-tumor necrosis factor-alpha monoclonal antibody)
    Burt, MJ
    Frizelle, FA
    Barbezat, GO
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (04) : 465 - U3
  • [6] Anti-tumor necrosis factor-α monoclonal antibody therapy for rheumatoid arthritis
    Kavanaugh, AF
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1998, 24 (03) : 593 - +
  • [7] Cardiovascular events and survival in rheumatoid arthritis: effects of anti-tumor necrosis factor-alpha treatment
    Cugno, Massimo
    [J]. TRANSLATIONAL RESEARCH, 2011, 157 (01) : 6 - 9
  • [8] Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis
    Tilg, H
    Jalan, R
    Kaser, A
    Davies, NA
    Offner, FA
    Hodges, SJ
    Ludwiczek, O
    Shawcross, D
    Zoller, H
    Alisa, A
    Mookerjee, RP
    Graziadei, N
    Datz, C
    Trauner, M
    Schuppan, D
    Obrist, P
    Vogel, W
    Williams, R
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 (04) : 419 - 425
  • [9] Anti-tumor necrosis factor-alpha antibody treatment reduces serum CXCL16 levels in patients with rheumatoid arthritis
    Kageyama, Yasunori
    Torikai, Eiji
    Nagano, Akira
    [J]. RHEUMATOLOGY INTERNATIONAL, 2007, 27 (05) : 467 - 472
  • [10] Anti-Tumor Necrosis Factor-Alpha Therapy and Periodontal Parameters in Patients With Rheumatoid Arthritis
    Mayer, Yaniv
    Balbir-Gurman, Alexandra
    Machtei, Eli E.
    [J]. JOURNAL OF PERIODONTOLOGY, 2009, 80 (09) : 1414 - 1420
12345